Harlan Pinto is an Oncology physician affiliated with Stanford Medicine. OpenAlex indexes 86 publications with 9,978 citations (h-index 36); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Pasteur Dr
Stanford, CA 943052200
Telephone
650-723-4000Provider last certified this registry record 16 Apr 2024.
Clinical trials
- Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
Sponsor: Stanford University
- Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer
Sponsor: Eastern Cooperative Oncology Group
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
31.6%Phenothiazine11.4%Prochlorperazine Maleate100%Part D<11 patientsOpioid Agonist10.5%Morphine Sulfate Er100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
28.9%Serotonin-3 Receptor Antagonist18.4%Ondansetron Hcl100%Part D<11 patientsProton pump inhibitor10.5%Omeprazole100%Part D<11 patientsHormonal (systemic)
17.5%l-Thyroxine17.5%Levothyroxine Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 1997–2000 per NIH RePORTER. The latest:
- IN VIVO 1H SPECTROSCOPY OF HEAD &NECK TUMORS: PO2 HISTOGRAPH MEASUREMENTS
Stanford University
FY1999P41RR009784
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Jeffrey Teuteberg, MD
Stanford Medicine
Charles Debattista, MD
Stanford Medicine
Michael Amylon, MD
Stanford Medicine
Kimberly Dequattro, MD, MM
Stanford Medicine
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”